A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects With Moderate to Severe Crohn's Disease
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects With Moderate to Severe Crohn's Disease
The purpose of this study is to assess the safety and effectiveness of BMS-986165 compared to placebo in participants with moderately to severely active Crohn's Disease.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria apply
Botucato, São Paulo 18618-970, Brazil
Copenhagen NV, 2400, Denmark
Sakura-shi, Chiba 285-8741, Japan
Kurume-shi, Fukuoka 830-0011, Japan
Sagamihara-shi, Kanagawa 2520375, Japan
Omura-shi, Nagasaki 8568562, Japan
Urasoe-Shi, Okinawa 901-2132, Japan
Suita-shi, Osaka 5650871, Japan
Bunkyo-ku, Tokyo 113-8519, Japan
Minato-ku, Tokyo 105-8471, Japan
Saint Petersburg, 195257, Russia
LHospitalet de Llobregat, 08907, Spain
Santiago de Compostelle, 15702, Spain
Cheshire, WA5 1QG, United Kingdom